|
|||||
|
|
Oral semaglutide improves postprandial glucose and lipid metabolism,and delays gastric emptying,in subjects with type 2 diabetes |
|
| Authors: | Kirsten Dahl DVM Ashley Brooks MBChB Firas Almazedi MBChB Søren Tetens Hoff MD Cristina Boschini PhD Tine A Bækdal MSc |
| Institution: | 1. Novo Nordisk A/S, Søborg, Denmark;2. Covance Clinical Research Unit Ltd, Leeds, UK |
| Abstract: | |
| Keywords: | dyslipidaemia GLP-1 analogue glycaemic control incretin therapy pharmacodynamics type 2 diabetes |